Haplotype specific alteration of diabetes MHC risk by olfactory receptor gene polymorphism

Autoimmunity Reviews

Volumn 12, Issue 2, 2012, Pages 270-274

  Jahromi, Mohamed M ^a  

^a Ministry of Health   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OLFACTORY RECEPTOR; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; HAPLOTYPES; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ODORANT;

EID: 84870240122     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.05.001     Document Type: Review

References (86)

1. Fan Wufang, Cai Weiwen, Parimoo Satish, Lennon Gregory G., Weissman Sherman M. Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics 1996, 44:97-103.
2. Bernstein Jonathan A., Zhang Ge, Jin Li, Abbott Carol, Nebert Daniel W. Olfactory receptor gene polymorphisms and nonallergic vasomotor rhinitis. J Asthma 2008, 45:287-292.
3. Kivity S., Ortega-Hernandez O.D., Shoenfeld Y. Olfaction-a window to the mind. Isr Med Assoc J 2009, 11:238-243.
4. Spehr Marc, Munger Steven D. Olfactory receptors: G protein-coupled receptors and beyond. J Neurochem 2009, 109:1570-1583.
5. Nakaoka Hirofumi, Cui Tailin, Tajima Atsushi, Oka Akira, Mitsunaga Shigeki, Kashiwase Koichi, et al. A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis. PLoS One 2011, 6:e25389.
6. Doty R.L., Li C., Mannon L.J., Yousem D.M. Olfactory dysfunction in multiple sclerosis: relation to longitudinal changes in plaque numbers in central olfactory structures. Neurology 1999, 53:880-882.
7. Burfoot R.K., Jensen C.J., Field J., Stankovich J., Varney M.D., Johnson L.J., Butzkueven H., et al. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 2008, 71:42-50.
8. Baranzini S.E. The genetics of autoimmune diseases: a networked perspective. Curr Opin Immunol Dec 2009, 21(6):596-605.
9. Ramos P.S., Criswell L.A., Moser K.L., Comeau M.E., Williams A.H., Pajewski N.M., et al. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 2011, 7:e1002406.
10. Menon Ramesh, Farina Cinthia Shared molecular and functional frameworks among five complex human disorders: a comparative study on interactomes linked to susceptibility genes. PLoS One 2011, 6:e18660.
11. Foster J., Sohrabi H., Verdile G., Martins R. Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction. Int Psychogeriatr 2008, 20:853-855.
12. Shaw C.A., Li Y., Wiszniewska J., Chasse S., Zaidi S.N., Jin W., et al. Olfactory copy number association with age at onset of Alzheimer disease. Neurology 2011, 76:1302-1309.
13. Teixeira Camargos Sarah, Oliveira Dornas Leonardo, Momeni Parastoo, Lees Andrew, Hardy John, Singleton Andrew, et al. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian Movement Disorders Clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1 and LRRK2 mutations. Mov Disord 2009, 24:662-666.
14. Chang X.L., Mao X.Y., Li H.H., Zhang J.H., Li N.N., Burgunder J.M., et al. Association of GWAS loci with PD in China. Am J Med Genet B Neuropsychiatr Genet 2011, 156:334-339.
15. Li Xinjun, Sundquist Jan, Sundquist Kristina Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden. Neurodegener Dis 2011, 1-8.
16. Peeraully T., Tan E.K. Genetic variants in sporadic Parkinson's disease: east vs west. Parkinsonism Relat Disord 2012, 18:S63-S65.
17. Perricone C., Agmon-Levin N., Shoenfeld N., De Carolis C., Guarino M.D., Gigliucci G., et al. Evidence of impaired sense of smell in hereditary angioedema. Allergy 2011, 66:149-154.
18. Katzav A., Solodeev I., Brodsky O., Chapman J., Pick C.G., Blank M., et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007, 56:938-948.
19. Strous Rael D., Shoenfeld Yehuda To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev 2006, 6:54-60.
20. Kivity Shaye, Ortega-Hernandez Oscar D., Shoenfeld Yehuda Olfaction - a window to the mind. IMAJ 2009, 11:238-243.
21. Benkler M., Agmon-Levin N., Shoenfeld Y. Parkinson's disease, autoimmunity, and olfaction. Int J Neurosci 2009, 119:2133-2143.
22. Cline G.D., Schwartz D.D., Axelrad M.E., Anderson B. A pilot study of acute stress symptoms in parents and youth following diagnosis of type I diabetes. J Clin Psychol Med Settings 2011, 18:416-422.
23. http://bioportal.weizmann.ac.il/HORDE/.
24. Safran M., Chalifa-Caspi V., Shmueli O., Olender T., Lapidot M., Rosen N., et al. Human gene-centric databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE. Nucleic Acids Res 2003, 31:142-146.
25. Tobar H.F., Moreno P.A., Vélez P.E. Highly conserved regions in the 5' region of human olfactory receptor genes. Genet Mol Res 2009, 8:117-128.
26. Menashe I., Man O., Lancet D., Gilad Y. Different noses for different people. Nat Genet 2003, 34:143-144.
27. Nguyen D.Q., Webber C., Ponting C.P. Bias of selection on human copy-number variants. PLoS Genet 2006, 2:e20.
28. Hasin Y., Olender T., Khen M., Gonzaga-Jauregui C., Kim P.M., Urban A.E., et al. High resolution copy-number variation map reflects human olfactory receptor diversity and evolution. PLoS Genet 2008, 4:e1000249.
29. Shoenfeld N., Agmon-Levin N., Flitman-Katzevman I., Paran B.S., Katz D., Kivity S., et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum 2009, 60:1484-1487.
30. Klimenkov I.V., Kositsyn N.S., Svinov M.M. Common features of stimulus-dependent differentiation of olfactory receptor neurons and B cells of the immune system. Dokl Biol Sci 2011, 436:6-8.
31. Buck Linda, Axel Richard A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 1991, 65:175-187.
32. Axel Richard Scents and sensibility: a molecular logic of olfactory perception (Nobel lecture). Angew Chem Int Ed Engl 2005, 44:6110-6127.
33. Shoenfeld Yehuda To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 2007, 28:165-169.
34. Takabatake N., Toriyama S., Takeishi Y., Shibata Y., Konta T., Inoue S., et al. A nonfunctioning single nucleotide polymorphism in olfactory receptor gene family is associated with the forced expiratory volume in the first second/the forced vital capacity values of pulmonary function test in a Japanese population. Biochem Biophys Res Commun 2007, 364:662-667.
35. Barcellos Lisa F., May Suzanne L., Ramsay Patricia P., Quach Hong L., Lane Julie A., Nititham Joanne, et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 2009, 5:e1000696.
36. Orozco G., Barton A., Eyre S., Ding B., Worthington J., Ke X., et al. HLA-DPB1-COL11A2 and three additional xMHC loci are independently associated with RA in a UK cohort. Genes Immun 2011, 12:169-175.
37. Fujikawa Teppei, Chuang Jen-Chieh, Sakata Ichiro, Ramadori Giorgio, Coppari Roberto Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. PNAS 2010, 107:17391-17396.
38. Tepavčević V., Lazarini F., Alfaro-Cervello C., Kerninon C., Yoshikawa K., Garcia-Verdugo J.M., et al. Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis. J Clin Invest 2011, 121:4722-4734.
39. Zhu Y.Y., Ni D.F., Xu C.M. Gene expression profiles in the olfactory bulb from a rat model of Alzheimer's disease. J Alzheimers Dis 2009, 18:581-593.
40. Vignal Charlotte, Bansal Aruna T., Balding David J., Binks Michae H., Dickson Marion C., Montgomery Doug S., et al. Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci. Arthritis Rheum 2009, 60:53-62.
41. Orozco G., Barton A., Eyre S., Din B., Worthington J., Ke X., et al. HLA-DPB1-COL11A2 and three additional xMHC loci are independently associated with RA in a UK cohort. Genes Immun 2011, 12:169-175.
42. Zhao Y., Jiang Z., Guo C. New hope for type 2 diabetics: targeting insulin resistance through the immune modulation of stem cells. Autoimmun Rev 2011, 11:137-142.
43. Van Der Net Jeroen B., Oosterveer Danier̈lla M., Versmissen Jorie, Defesche Joep C., Yazdanpanah Mojgan, Aouizerat Bradley E., et al. Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia. European Heart Journal 2008, 29:2195-2201.
44. Ortega-Hernandez O.D., Kivity S., Shoenfeld Y. Olfaction, psychiatric disorders and autoimmunity: is there a common genetic association?. Autoimmunity 2009, 42:80-88.
45. Weinstock R.S., Wright H.N., Smith D.U. Olfactory dysfunction in diabetes mellitus. Physiol Behav 1993, 53:17-21.
46. Le Floch J.P., Le Lièvre G., Labroue M., Paul M., Peynegre R., Perlemuter L. Smell dysfunction and related factors in diabetic patients. Diabetes Care 1993, 16:934-937.
47. King G.L., Loeken M.R. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004, 122:333-338.
48. Hoeldtke R.D., Bryner K.D., Vandyke K. Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res 2011, 21:19-28.
49. Brands A.M., Kessels R.P., De Haan E.H., Kappelle L.J., Biessels G.J. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol 2004, 490:159-168.
50. Sima A.A., Zhang W., Muzik O., Kreipke C.W., Rafols J.A., Hoffman W.H. Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-peptide. Rev Diabet Stud 2009, 6:211-222.
51. Sima A.A. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010, 47:279-293.
52. Hoffman W.H., Andjelkovic A.V., Zhang W., Passmore G.G., Sima A.A. Insulin and IGF-1 receptors, nitrotyrosin and cerebral neuronal deficits in two young patients with diabetic ketoacidosis and fatal brain edema. Brain Res 2010, 1343:168-177.
53. Mira A.D., Ward H. Encephalopathy following diabetic ketoacidosis in a type 1 diabetes patient. Pract Diab Int 2010, 27:76-78.
54. Guven A., Cebeci N., Dursun A., Aktekin E., Baumgartner M., Fowler B. Methylmalonic acidemia mimicking diabetic ketoacidosis in an infant. Pediatr Diabetes May 5 2011, 10.1111/j.1399-5448.2011.00784.x.
55. Fritsch M., Rosenbauer J., Schober E., Neu A., Placzek K., Holl R.W. German competence network diabetes mellitus and the DPV initiative. Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database. Pediatr Diabetes 2011, 12:307-312.
56. Hawkins K.A., Pearlson G.D. Age and gender but not common chronic illnesses predict odor identification in older African Americans. Am J Geriatr Psychiatry 2011, 19:777-782.
57. Grassi M.A., Tikhomirov A., Ramalingam S., Below J.E., Cox N.J., Nicolae D.L. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 2011, 20:2472-2481.
58. Kornete M., Piccirillo C.A. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in type I diabetes. Autoimmun Rev 2011, 11:104-111.
59. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996, 59:1134-1148.
60. Lambert A. Paul, Gillespie Kathleen M., Thomson Glenys, Cordell Heather J., Todd John A., Gale Edwin A.M., et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 2004, 89:4037-4043.
61. Rewers M., Bugawan T.L., Norris J.M., Blair A., Beaty B., Hoffman M., et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996, 39:807-812.
62. Johansson S., Lie B.A., Todd J.A., Pociot F., Nerup J., Cambon-Thomsen A., et al. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun 2003, 4:46-53.
63. Aly T.A., Ide A., Jahromi M.M., Barker J.M., Fernando M.S., Babu S.R., et al. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A 2006, 103:14074-14079.
64. Cheung Y.H., Watkinson J., Anastassiou D. Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHC. Hum Genet 2011, 129:161-176.
65. Nejentsev Sergey, Howson Joanna M.M., Walker Neil M., Szeszko Jeffrey, Field Sarah F., Stevens Helen E., et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007, 450:887-892.
66. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
67. Aly Theresa A., Baschal Erin E., Jahromi Mohamed M., Fernando Maria S., Babu Sunanda R., Fingerlin Tasha E., et al. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes 2008, 57:770-776.
68. Baschal E.E., Aly T.A., Jasinski J.M., Steck A.K., Johnson K.N., Noble J.A., et al. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes. Diabetes Obes Metab 2009, 11:25-30.
69. Concannon P., Chen W.M., Julier C., Morahan G., Akolkar B., Erlich H.A., et al. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009, 58:1018-1022.
70. Pociot F., Akolkar B., Concannon P., Erlich H.A., Julier C., Morahan G., et al. Genetics of type 1 diabetes: what's next?. Diabetes 2010, 59:1561-1571.
71. Zhang B.Y., Zhang J., Liu J.S. Block-based Bayesian epistasis association mapping with application to WTCCC type 1 diabetes data. Ann Appl Stat 2011, 5:2052-2077.
72. Younger R.M., Amadou C., Bethel G., Ehlers A., Lindahl K.F., Forbes S., et al. Characterization of clustered MHC-linked olfactory receptor-genes in human and mouse. Genome Res 2001, 11:519-530.
73. Santos P.S., Seki Uehara C.J., Ziegler A., Uchanska-Ziegler B., Bicalho Mda G. Variation and linkage disequilibrium within odorant receptor gene clusters linked to the human major histocompatibility complex. Hum Immunol 2010, 719:843-850.
74. Derynck R., Rhee L., Chen E.Y., Tilburg A.V. Intron-exon structure of the human transforming growth factor-β precursor gene. Nucleic Acid Res 1987, 15:3188-3189.
75. Malnic Bettina, Godfrey Paul A., Buck Linda B. The human olfactory receptor gene family. PNAS 2004, 101:2584-2589.
76. Northam Elisabeth A., Rankins Debbie, Lin Ashleigh, Wellard R. Mark, Pell Gaby S., Finch Sue J., et al. Central nervous system. Function in youth with type 1 diabetes 12years after disease onset. Diabetes Care 2009, 32:445-450.
77. Stiles M.C., Seaquist E.R. Cerebral structural and functional changes in type 1 diabetes. Minerva Med 2010, 101:105-114.
78. Aye Tandy, Reiss Allan L., Kesler Shelli, Hoang Sherry, Drobny Jessica, Park Yaena, et al. The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care 2011, 34:1458-1462.
79. Roriz-Filho J S., Sá-Roriz T.M., Rosset I., Camozzato A.L., Santos A.C., Chaves M.L., et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792:432-443.
80. Asvold B.O., Sand T., Hestad K., Bjørgaas M.R. Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study. Diabetes Care 2010, 33:1945-1947.
81. Bessen Richard A., Shearin Harold, Martinka Scott, Boharski Ryan, Lowe Diana, Wilham Jason M., et al. Prion shedding from olfactory neurons into nasal secretions. PLoS Pathog 2010, 6:e1000837.
82. Fiorina Paolo, Vezzulli Paolo, Bassi Roberto, Gremizzi Chiara, Falautano Monica, D'Addio Francesca, et al. Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation. Diabetes Care February 2012, 35:367-374.
83. Delgado-Vega A., Sánchez S., Löfgren E., Castillejo-López C., Alarcón-Riquelme M.E. Recent findings on genetics of systemic autoimmune diseases. Curr Opin Immunol 2010, 22:698-705.
84. Lie A.B., Thorsby E. Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr Opin Immunol 2005, 17:526-531.
85. Lewis Stephanie N., Nsoesie Elaine, Weeks Charles, Qiao Dan, Zhang Liqing Prediction of disease and phenotype associations from genome-wide association studies. PLoS ONE 2011, 6:e27175.
86. Anaya J.M., Kim-Howard X., Prahalad S., Cherñavsky A., Cañas C., Rojas-Villarraga A., et al. Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmun Rev 2012, 11:276-280.